Abiopharma

New Form DEFA14A - Lyra Therapeutics, Inc. Filed: 2025-05-09 AccNo: 0001193125-25-116890 Size: 11 KB

New Form 8-K - DEXCOM INC Filed: 2025-05-09 AccNo: 0001093557-25-000129 Size: 762 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements and Exhibits

New Form SCHEDULE 13G/A - TENET HEALTHCARE CORP Filed: 2025-05-09 AccNo: 0000914208-25-000190 Size: 7 KB

New Form 4 - Corvus Pharmaceuticals, Inc. Filed: 2025-05-09 AccNo: 0001610717-25-000115 Size: 7 KB

New Form ARS - enGene Holdings Inc. Filed: 2025-05-09 AccNo: 0001140361-25-018160 Size: 2 MB

New Form 10-Q - Azenta, Inc. Filed: 2025-05-09 AccNo: 0001437749-25-015776 Size: 11 MB

New Form 4 - Harmony Biosciences Holdings, Inc. Filed: 2025-05-09 AccNo: 0001415889-25-012477 Size: 8 KB

New Form 8-K - Surrozen, Inc./DE Filed: 2025-05-09 AccNo: 0000950170-25-068011 Size: 433 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 144 - Harmony Biosciences Holdings, Inc. Filed: 2025-05-09 AccNo: 0001950047-25-002826 Size: 8 KB

New Form SCHEDULE 13G - Twist Bioscience Corp Filed: 2025-05-09 AccNo: 0001644956-25-000023 Size: 6 KB

New Form 8-K - Allarity Therapeutics, Inc. Filed: 2025-05-09 AccNo: 0001437749-25-015778 Size: 285 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 4 - Safety Shot, Inc. Filed: 2025-05-09 AccNo: 0001641172-25-009447 Size: 4 KB

New Form SCHEDULE 13G/A - Oncocyte Corp Filed: 2025-05-09 AccNo: 0001535264-25-000041 Size: 10 KB

New Form S-3 - ACADIA PHARMACEUTICALS INC Filed: 2025-05-09 AccNo: 0001193125-25-116883 Size: 399 KB

BeiGene annonce ses résultats financiers et ses mises à jour commerciales pour le premier trimestre de 2025